Insider trading

Period: 120 months Stock: ROIV + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

227 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

227 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

227 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

227 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
227 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
227 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

227 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
31 Dec 2025
Sukhatme Mayukh President & CIO
Sold at will
$22.12M 1,018,995 at 21.71
4.8%
Not planned
29 Dec 2025
Sukhatme Mayukh President & CIO
Sold at will
$6.78M 311,873 at 21.74
1.6%
Not planned
24 Dec 2025
Venker Eric President & Immunovant CEO
Sold at will
$1.69M 75,000 at 22.53
4.3%
Not planned
23 Dec 2025
Sold at will 2×
$9.12M 406,731 at 22.43
62.9%
Sold half or more
23 Dec 2025
Venker Eric President & Immunovant CEO
Sold at will
$4.49M 200,000 at 22.45
11.0%
Not planned
17 Dec 2025
MANCHESTER KEITH S Director · indirect
Sold at will 3×
$17.94M 777,332 at 23.07
4.5%
Not planned
17 Dec 2025
Gold Daniel Allen Director · indirect
Sold at will 3×
$17.94M 777,332 at 23.07
4.5%
Not planned
17 Dec 2025
QVT Financial LP Director by Deputization · indirect
Sold at will 3×
$17.94M 777,332 at 23.07
4.5%
Not planned
17 Dec 2025
Sukhatme Mayukh President & CIO
Sold at will
$619.53K 26,831 at 23.09
0.1%
Not planned
16 Dec 2025
QVT Financial LP Director by Deputization · indirect
Sold at will 2×
$21.13M 917,282 at 23.04
5.1%
Not planned
16 Dec 2025
MANCHESTER KEITH S Director · indirect
Sold at will 2×
$21.13M 917,282 at 23.04
5.1%
Not planned
16 Dec 2025
Gold Daniel Allen Director · indirect
Sold at will 2×
$21.13M 917,282 at 23.04
5.1%
Not planned
15 Dec 2025
Sold at will 3×
$37.72M 1,740,000 at 21.68
9.1%
Not planned
15 Dec 2025
Ramaswamy Vivek 10% owner
Sold at will
$7.80M 353,745 at 22.05
1.0%
Not planned
12 Dec 2025
Ramaswamy Vivek 10% owner
Sold at will
$43.39M 1,975,858 at 21.96
5.2%
Not planned
11 Dec 2025
Ramaswamy Vivek 10% owner
Sold at will
$16.75M 774,142 at 21.64
2.2%
Not planned
9 Dec 2025
Venker Eric President & Immunovant CEO
Sold on a plan
$4.17M 200,000 at 20.85
11.8%
Planned (10b5-1)
19 Nov 2025
QVT Financial LP Director by Deputization · indirect
Sold at will 4×
$26.30M 1,300,000 at 20.23
6.7%
Not planned
19 Nov 2025
Gold Daniel Allen Director · indirect
Sold at will 4×
$26.30M 1,300,000 at 20.23
6.7%
Not planned
19 Nov 2025
MANCHESTER KEITH S Director · indirect
Sold at will 4×
$26.30M 1,300,000 at 20.23
6.7%
Not planned
17 Nov 2025
Ramaswamy Vivek 10% owner
Sold at will
$11.07M 539,650 at 20.51
1.6%
Not planned
14 Nov 2025
Ramaswamy Vivek 10% owner
Sold at will
$20.89M 1,027,670 at 20.33
2.9%
Not planned
13 Nov 2025
Ramaswamy Vivek 10% owner
Sold at will
$5.98M 287,283 at 20.81
0.8%
Not planned
7 Nov 2025
Venker Eric President & Immunovant CEO
Sold on a plan
$4.04M 200,000 at 20.22
11.7%
Planned (10b5-1)
17 Oct 2025
Venker Eric President & Immunovant CEO
Sold on a plan
$2.02M 118,418 at 17.06
7.3%
Planned (10b5-1)
16 Oct 2025
Venker Eric President & Immunovant CEO
Sold on a plan
$5.43M 318,282 at 17.05
17.5%
Planned (10b5-1)
15 Oct 2025
Venker Eric President & Immunovant CEO
Sold on a plan
$7.02M 414,683 at 16.93
21.6%
Planned (10b5-1)
13 Oct 2025
Venker Eric President & Immunovant CEO
Sold on a plan
$336.81K 20,727 at 16.25
1.4%
Planned (10b5-1)
9 Oct 2025
Venker Eric President & Immunovant CEO
Sold on a plan
$1.71M 104,940 at 16.30
6.5%
Planned (10b5-1)
8 Oct 2025
Venker Eric President & Immunovant CEO
Sold on a plan
$2.25M 138,602 at 16.20
8.4%
Planned (10b5-1)
7 Oct 2025
Venker Eric President & Immunovant CEO
Sold on a plan
$5.74M 355,161 at 16.15
19.1%
Planned (10b5-1)
6 Oct 2025
Venker Eric President & Immunovant CEO
Sold on a plan
$2.80M 171,396 at 16.34
10.2%
Planned (10b5-1)
23 Sep 2025
Venker Eric President & Immunovant CEO
Sold on a plan
$9.06M 611,000 at 14.83
28.9%
Planned (10b5-1)
22 Sep 2025
Venker Eric President & Immunovant CEO
Sold on a plan 2×
$6.24M 416,182 at 14.99
16.4%
Planned (10b5-1)
19 Sep 2025
Venker Eric President & Immunovant CEO
Sold on a plan
$10.22M 683,818 at 14.95
25.8%
Planned (10b5-1)
18 Sep 2025
Bought
$49.96K 3,315 at 15.07
0.0%
First buy on file
5 Sep 2025
Ramaswamy Vivek 10% owner
Sold at will
$5.00M 385,816 at 12.96
1.1%
Not planned
4 Sep 2025
Ramaswamy Vivek 10% owner
Sold at will
$2.52M 194,933 at 12.92
0.5%
Not planned
3 Sep 2025
Ramaswamy Vivek 10% owner
Sold at will
$14.94M 1,195,000 at 12.50
3.2%
Not planned
20 Aug 2025
Venker Eric President & Immunovant CEO
Sold on a plan
$1.17M 100,000 at 11.72
5.7%
Planned (10b5-1)
21 Jul 2025
Venker Eric President & Immunovant CEO
Sold on a plan
$1.15M 100,000 at 11.52
6.4%
Planned (10b5-1)
20 Jun 2025
Ramaswamy Vivek 10% owner
Sold at will
$6.61M 577,007 at 11.46
1.5%
Not planned
20 Jun 2025
Venker Eric President & COO
Sold on a plan
$1.15M 100,000 at 11.45
6.4%
Planned (10b5-1)
18 Jun 2025
Ramaswamy Vivek 10% owner
Sold at will
$6.47M 565,266 at 11.45
1.5%
Not planned
6 Jun 2025
Ramaswamy Vivek 10% owner
Sold at will
$2.25M 200,800 at 11.19
0.5%
Not planned
4 Jun 2025
Ramaswamy Vivek 10% owner
Sold at will
$6.21M 547,430 at 11.34
1.4%
Not planned
3 Jun 2025
Venker Eric President & COO
Sold at will
$6.35M 566,278 at 11.22
27.9%
Not planned
2 Jun 2025
Venker Eric President & COO
Sold at will
$4.80M 433,722 at 11.07
25.9%
Not planned
20 May 2025
Venker Eric President & COO
Sold on a plan
$1.10M 100,000 at 10.95
8.5%
Planned (10b5-1)
7 May 2025
Ramaswamy Vivek 10% owner
Sold at will
$6.99M 625,000 at 11.18
1.6%
Not planned
Showing 51–100 of 227. ← Newer Page 2 of 5 Older →